This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Eli Lilly and Co (LLY)

NYSE: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 19.96B 19.62B 23.11B 22.60B
Cost of Sales 3.61B 3.55B 3.46B 3.33B
Gross Operating Profit 16.35B 16.06B 19.65B 19.27B
Selling, General, and Administrative Expenses 6.53B 6.62B 7.13B 7.51B
Research & Development 5.33B 4.73B 5.53B 5.28B
Operating Income before D & A (EBITDA) 4.48B 4.71B 6.99B 6.48B
Depreciation & Amortization 1.43B 1.38B 1.45B 1.46B
Interest Income 0.00 121.00M 119.70M 105.00M
Other Income - Net -267.10M -300.60M 559.30M 0.00
Special Income / Charges 0.00 0.00 -234.80M 465.70M
Total Income Before Interest Expenses (EBIT) 2.79B 3.15B 6.05B 5.59B
Interest Expense 0.00 148.80M 160.10M 177.80M
Pre-Tax Income 2.79B 3.00B 5.89B 5.41B
Income Taxes 381.60M 609.80M 1.20B 1.32B
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 2.41B 2.39B 4.68B 4.09B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.41B 2.39B 4.68B 4.09B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.41B 2.39B 4.68B 4.09B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.41B 2.39B 4.86B 3.62B
Preferred Dividends
Net Income Available To Common 2.41B 2.39B 4.68B 4.09B
Basic EPS from Continuing Ops. 2.27 2.23 4.33 3.67
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.27 2.23 4.33 3.67
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.27 2.23 4.33 3.67
Basic Normalized Net Income/Share 2.27 2.23 4.50 3.25
EPS fr Continuing Ops. 2.26 2.23 4.32 3.66
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.26 2.23 4.32 3.66
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.26 2.23 4.32 3.66
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.26 2.23 4.48 3.24
Dividends Paid per Share 2.00 1.96 1.96 1.96
LLY News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

LLY Eli Lilly and Co

Chart of LLY

Analysts Ratings for LLY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 9 9 9
Moderate Buy 0 0 0 0
Hold 4 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0
GET LLY ANALYST REPORT

LLY Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs